RAB11FIP5

Across TCGA pan-cancer cohorts, RAB11FIP5 RNA is linked to patient survival in 22 of 34 cancer types, making it the most broadly survival-associated RAB11FIP5 data layer compared with 3 for mutation status and 4 for mass-spec protein.

The strongest signal is observed in mesothelioma (MESO), where higher RAB11FIP5 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RAB11FIP5 expression acts as an unfavorable survival marker, although some lineages such as KIRC and CHOL show a favorable association.

MESO, ACC, and KIRC are the cancer types where RAB11FIP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Median	All	0.272	0.495	<.001	108	view →
ACC	DFS	Median	All	0.236	0.638	<.001	89	view →
KIRC	OS	Median	All	0.746	0.519	<.001	85	view →
LIHC	DFS	Quartile	All	0.389	0.631	<.001	78	view →
BLCA	DFS	Tertile	All	0.291	0.484	<.001	56	view →
OV	OS	Tertile	All	0.251	0.363	.005	42	view →
UCEC	DFS	Quartile	All	0.684	0.857	.005	38	view →
CESC	DFS	Quartile	All	0.667	0.875	.001	34	view →
PAAD	DFS	Quartile	All	0.204	0.465	.006	27	view →
LGG	OS	Median	All	0.761	0.897	.002	23	view →
LUAD	DFS	Quartile	All	0.267	0.439	.008	20	view →
KICH	OS	Median	III,IV	0.467	0.863	.011	13	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 22 lineages.

RAB11FIP5–MESO (OS)

Open the MESO breakdown →